Green Cures Financials
| GRCU Stock | USD 0.0001 0.0001 50.00% |
Green |
Understanding current and past Green Cures Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Green Cures' financial statements are interrelated, with each one affecting the others. For example, an increase in Green Cures' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Green Cures' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Green Cures Botanical. Check Green Cures' Beneish M Score to see the likelihood of Green Cures' management manipulating its earnings.
Green Cures Stock Summary
Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US3930072083 |
| Business Address | 11222 S La |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | greencurescorp.com |
| Phone | 888 509 8085 |
| Currency | USD - US Dollar |
Green Cures Key Financial Ratios
Green Cures' financial ratios allow both analysts and investors to convert raw data from Green Cures' financial statements into concise, actionable information that can be used to evaluate the performance of Green Cures over time and compare it to other companies across industries.Green Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Green Cures's current stock value. Our valuation model uses many indicators to compare Green Cures value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Cures competition to find correlations between indicators driving Green Cures's intrinsic value. More Info.Green Cures Botanical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.04 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Green Cures Botanical is roughly 23.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Green Cures' earnings, one of the primary drivers of an investment's value.Green Cures Botanical Systematic Risk
Green Cures' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Green Cures volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Green Cures Botanical correlated with the market. If Beta is less than 0 Green Cures generally moves in the opposite direction as compared to the market. If Green Cures Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Green Cures Botanical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Green Cures is generally in the same direction as the market. If Beta > 1 Green Cures moves generally in the same direction as, but more than the movement of the benchmark.
Green Cures January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Green Cures help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Green Cures Botanical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Green Cures Botanical based on widely used predictive technical indicators. In general, we focus on analyzing Green Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Green Cures's daily price indicators and compare them against related drivers.
| Downside Deviation | 51.64 | |||
| Information Ratio | 0.1982 | |||
| Maximum Drawdown | 150.0 | |||
| Value At Risk | (50.00) | |||
| Potential Upside | 100.0 |
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.